Related Experiment Video
Updated: Feb 11, 2026

Murine Model of Leukemia Relapse to Induction Chemotherapy for Acute Lymphoblastic Leukemia
Published on: October 17, 2025
Acute lymphoblastic leukemia: diagnosis and detection of minimal residual disease following therapy
1Department of Pathology & Laboratory Medicine, Special Hematology Laboratory, Hartford Hospital, 80 Seymour Street, Hartford, CT 06102-5037, USA. jdigius@harthosp.org
Insights
Flow cytometric immunophenotyping (FCI) aids in diagnosing acute lymphoblastic leukemia (ALL) by identifying leukemic cells. This method also detects minimal residual disease, crucial for prognosis and tailored treatments.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Acute lymphoblastic leukemia (ALL) diagnosis relies on accurate methods.
- Flow cytometric immunophenotyping (FCI) is a key diagnostic tool.
Purpose of the Study:
- To highlight the role of FCI in diagnosing and managing ALL.
- To emphasize FCI's prognostic value in minimal residual disease detection.
Main Methods:
- Utilizing flow cytometry for rapid identification and characterization of leukemic blasts.
- Employing FCI for sensitive detection of minimal residual disease post-therapy.
Main Results:
- FCI enables accurate and timely diagnosis of ALL.
- FCI can predict cytogenetic and molecular abnormalities.
- Minimal residual disease detection by FCI is a strong prognostic indicator.
Conclusions:
- FCI is essential for ALL diagnosis, classification, and prognosis.
- FCI facilitates risk-adapted therapy through precise minimal residual disease monitoring.
Abstract:
Flow cytometric immunophenotyping (FCI) is an important diagnostic modality in the evaluation of patients who have suspected or known acute lymphoblastic leukemia (ALL). It enables rapid identification, quantification, and immunophenotypic characterization of leukemic blasts, permitting accurate and timely diagnosis. Beyond facilitating the classification of ALL into fundamental diagnostic categories, FCI may anticipate recurrent cytogenetic and molecular abnormalities. FCI permits the detection of leukemic blasts after therapy at a level lower than that achievable by conventional microscopic examination. Flow cytometric detection of minimal residual disease is among the strongest prognostic factors in patients who have ALL and may provide an opportunity for more precise risk-adapted therapies.
Related Concept Videos
Types of Errors: Detection and Minimization
Absolute error in a measurement is the numerical difference from the true or central value. Relative error is the ratio between absolute error and the true or central value, expressed as a percentage.
Errors can be classified by source, magnitude, and sign. There are three types of errors: systematic, random, and gross.
Systematic or...
Residual Plots
When the residual values are plotted against the variable x, it is called a residual...
Residual Stresses
Gene Therapy
Residual Stresses in Circular Shafts
Residual Stresses in Bending

